SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suraksha Diagnostic informs about investor presentation

21 Dec 2024 Evaluate
Suraksha Diagnostic has informed that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to the intimation dated 18 December 2024 regarding schedule of Analyst(s)/ Investor(s) Meet /Conference, Earnings Call on Monday, 23 December 2024 at 11:00 am (IST), it enclosed a copy of Investor Presentation on the unaudited financial results (both standalone and consolidated) of the Company for quarter and six months ended 30 September 2024. The Investor Presentation will be exhibited at the aforesaid Earnings Call and the same will be available on the website of the Company at www.surakshanet.com.

The above information is a part of company’s filings submitted to BSE.

Suraksha Diagnostic Share Price

282.05 0.60 (0.21%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×